Angde Biotech Pharmaceutical Co., Ltd.

Quick facts

Phase 3 pipeline

• Recombinant human tissue plasminogen activator · Cardiovascular
  Recombinant human tissue plasminogen activator (rtPA) converts plasminogen to plasmin, which breaks down fibrin clots to restore blood flow.

Phase 2 pipeline

• Alteplase for Injection · Cardiovascular
  Alteplase for Injection is a tissue plasminogen activator that works by dissolving blood clots.
• r-PA

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Angde Biotech Pharmaceutical Co., Ltd. portfolio CI brief
• Angde Biotech Pharmaceutical Co., Ltd. pipeline updates RSS